Envelope surface glycoprotein gp120
|
env
|
Ab-dependent activation of NK cells to upregulate the expression of CD107a is most robust when the NK cells are stimulated with HIV-1 gp120-coated primary T cells in the presence of HIV-1 infected plasma |
PubMed
|
|
env
|
HIV-1 gp120 co-localizes with LAMP-1 in human plasmacytoid dendritic cells |
PubMed
|
Envelope surface glycoprotein gp160, precursor
|
env
|
HIV-1 Env co-localizes with LAMP1 in lysosomes |
PubMed
|
|
env
|
LAMP1 localizes to endosome compartments and is incorporated into the viral envelope of macrophage-derived HIV-1 particles |
PubMed
|
Envelope transmembrane glycoprotein gp41
|
env
|
HIV-1 gp41 mutants W614A, S615A, N616A, and S618A downregulates the cellular surface expression of CD107a on NK-cells |
PubMed
|
Nef
|
nef
|
HIV-1 Nef sequesters HLA-I A2 and co-localizes with CD63 and LAMP1 markers in late endosomes and lysosomes |
PubMed
|
|
nef
|
Both HIV-1 Nef and Vpu downregulate the cell surface expression of lysosomal-associated membrane protein 1 (CD107a) |
PubMed
|
|
nef
|
The proportion of HIV-1 Nef-specific CD8+ T cells endowed with TNF-alpha+, IFN-gamma+, CD107a+, and MIP-1beta+ is significantly higher in patients with the lowest virus set point than those with the highest virus set point |
PubMed
|
|
nef
|
HIV-1 Nef co-localizes with CXCR4, AIP4, NEDD4, CD63/LAMP-1-positive vesicles, and HRS/VPS27-positive ESCRT-0 structures in HeLa cells |
PubMed
|
Pr55(Gag)
|
gag
|
Co-localization of HIV-1 Gag virus-like particles in THP-1/CD169YF cells is reduced within CD81+ compartments, but enhanced within CD63+ or LAMP1+ compartments |
PubMed
|
|
gag
|
The proportion of HIV-1 Gag-specific CD8+ T cells endowed with TNF-alpha+, IFN-gamma+, CD107A+, and MIP-1beta+ is significantly higher in patients with the lowest virus set point than those with the highest virus set point |
PubMed
|
|
gag
|
LAMP-mediated upregulation of HIV-1 LAMP-Gag fusion protein expression is dependent on the LAMP luminal domain, leading to induce LAMP-Gag secretion through exosomes |
PubMed
|
|
gag
|
In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments |
PubMed
|
|
gag
|
HIV-1 Gag co-localizes with Rab7-, Rab9-, and LAMP1-containing membranes at cytoplasmic and juxtanuclear sites in Staufen1-depleted cells |
PubMed
|
|
gag
|
HIV-1 Gag and viral RNA co-localize with LAMP1 in lysosomes |
PubMed
|
|
gag
|
Gag myristoylation is important for the co-trafficking of HIV-1 RNA and Gag on LAMP-1+ membranes. Gag nucleocapsid mutations lead to a loss of colocalization between LAMP-1 and HIV-1 RNA or Gag |
PubMed
|
|
gag
|
HIV-1 RNA is distributed throughout the cytoplasm in a punctate pattern, at the plasma membrane , and partially co-localizes with both Gag and LAMP-1 in the perinuclear region |
PubMed
|
Tat
|
tat
|
HIV-1 Tat upregulates LAMP1 on the surface of primary astrocytes, which is a measurement for lysosomal exocytosis |
PubMed
|
Vpr
|
vpr
|
HIV-1 YU-2 or ADA Vpr inhibits LAMP1 recruitment to and maturation of phagosomes in primary human macrophages |
PubMed
|
|
vpr
|
HIV-1 Vpr abrogates co-localization of LAMP1 with HIV-1 MA (p17) (lysosomal targeting) in monocyte-derived macropaphages |
PubMed
|
|
vpr
|
HIV-1 Vpr impairs NK cell function through cytokine dysregulation, including diminshed expression of CD107a, reduced production of IFN-gamma, differential regulation of IL-12 and TGF-beta, and activation of the Smad3 signalling pathway |
PubMed
|
Vpu
|
vpu
|
Both HIV-1 Nef and Vpu downregulate the cell surface expression of lysosomal-associated membrane protein 1 (CD107a) |
PubMed
|
|
vpu
|
Expression of HIV-1 Vpu induces co-localization of tetherin with early endosome protein EEA-1 or late endosome protein LAMP-1 |
PubMed
|
capsid
|
gag
|
HIV-1 CA-stimulated CD8+ T cells upregulate CD107 expression compared to unstimulated cells |
PubMed
|
|
gag
|
In human macrophages, HIV-1 Capsid (p24) co-localizes with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments |
PubMed
|
matrix
|
gag
|
HIV-1 MA (p17) colocalizes with LAMP1 (lysosomal targeting) in the absense of Vpr in monocyte-derived macrophages |
PubMed
|